Kuipers E J
Department of Gastroenterology, Free University Hospital, Amsterdam, The Netherlands.
Aliment Pharmacol Ther. 1998 Feb;12 Suppl 1:25-36. doi: 10.1111/j.1365-2036.1998.00009.x.
Helicobacter pylori causes chronic active inflammation of the gastric mucosa in the majority of infected patients. In a considerable number of them, this will eventually lead to a loss of gastric glands, and thus the establishment of atrophic gastritis. This is associated with the development of intestinal metaplasia and dysplasia. These consecutive conditions increase the risk for gastric cancer. particularly of the intestinal type. We reviewed the evidence that H. pylori plays an important role in this sequence of events that can lead to gastric cancer. This paper focuses on the difficulties in staging atrophic gastritis, the incidence and prevalence of this condition and the relation with H. pylori infection. Furthermore, it describes the evidence for the role of this organism and gastric mucosal atrophy in the aetiology of gastric cancer and focuses on the life-time incidence of gastric cancer in the presence of this bacterium.
幽门螺杆菌在大多数感染患者中会引起胃黏膜的慢性活动性炎症。在相当多的患者中,这最终会导致胃腺丧失,从而形成萎缩性胃炎。这与肠化生和发育异常的发展有关。这些连续的病症会增加患胃癌的风险,尤其是肠型胃癌。我们回顾了幽门螺杆菌在这一系列可能导致胃癌的事件中起重要作用的证据。本文重点关注萎缩性胃炎分期的困难、这种病症的发病率和患病率以及与幽门螺杆菌感染的关系。此外,它描述了这种微生物和胃黏膜萎缩在胃癌病因学中的作用证据,并重点关注存在这种细菌时胃癌的终生发病率。